These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 33086941)

  • 41. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spirituelles Wohlbefinden und Coping bei Sklerodermie, Lupus erythematodes und malignem Melanom.
    Pilch M; Scharf SN; Lukanz M; Wutte NJ; Fink-Puches R; Glawischnig-Goschnik M; Unterrainer HF; Aberer E
    J Dtsch Dermatol Ges; 2016 Jul; 14(7):717-29. PubMed ID: 27373246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Role of Spirituality and Religiosity in Persons Living With Sickle Cell Disease: A Review of the Literature.
    Clayton-Jones D; Haglund K
    J Holist Nurs; 2016 Dec; 34(4):351-360. PubMed ID: 26620813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morphologische Kriterien vesikulobullöser Hauterkrankungen in der konfokalen In-vivo-Laserscanmikroskopie.
    Samhaber KT; Buhl T; Brauns B; Hofmann L; Mitteldorf C; Seitz CS; Schön MP; Rosenberger A; Haenssle HA
    J Dtsch Dermatol Ges; 2016 Aug; 14(8):797-806. PubMed ID: 27509414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A qualitative analysis of best self-management practices: sickle cell disease.
    Tanabe P; Porter J; Creary M; Kirkwood E; Miller S; Ahmed-Williams E; Hassell K
    J Natl Med Assoc; 2010 Nov; 102(11):1033-41. PubMed ID: 21141291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pain among children and adolescents: restrictions in daily living and triggering factors.
    Roth-Isigkeit A; Thyen U; Stöven H; Schwarzenberger J; Schmucker P
    Pediatrics; 2005 Feb; 115(2):e152-62. PubMed ID: 15687423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stigma and Pain in Adolescents Hospitalized for Sickle Cell Vasoocclusive Pain Episodes.
    Martin SR; Cohen LL; Mougianis I; Griffin A; Sil S; Dampier C
    Clin J Pain; 2018 May; 34(5):438-444. PubMed ID: 28877143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.
    Asnani MR; Quimby KR; Bennett NR; Francis DK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011175. PubMed ID: 27711980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A biopsychosocial model for the management of patients with sickle-cell disease transitioning to adult medical care.
    Crosby LE; Quinn CT; Kalinyak KA
    Adv Ther; 2015 Apr; 32(4):293-305. PubMed ID: 25832469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exploring the Needs of Adolescents With Sickle Cell Disease to Inform a Digital Self-Management and Transitional Care Program: Qualitative Study.
    Kulandaivelu Y; Lalloo C; Ward R; Zempsky WT; Kirby-Allen M; Breakey VR; Odame I; Campbell F; Amaria K; Simpson EA; Nguyen C; George T; Stinson JN
    JMIR Pediatr Parent; 2018 Sep; 1(2):e11058. PubMed ID: 31518307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deutsches "Nationales Krebshilfe-Monitoring" 2015-2019 - Studienprotokoll und erste Ergebnisse.
    Schneider S; Görig T; Schilling L; Breitbart EW; Greinert R; Diehl K
    J Dtsch Dermatol Ges; 2017 Sep; 15(9):895-904. PubMed ID: 28872230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transition from pediatric to adult care in sickle cell disease: perspectives on the family role.
    Porter JS; Graff JC; Lopez AD; Hankins JS
    J Pediatr Nurs; 2014; 29(2):158-67. PubMed ID: 24188784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of birth date on growth performance of calves of seasonally-bred range cattle.
    Rege JE; Moyo S
    J Anim Breed Genet; 1993 Jan; 110(1-6):209-27. PubMed ID: 21395720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Self-efficacy, transition, and patient outcomes in the sickle cell disease population.
    Molter BL; Abrahamson K
    Pain Manag Nurs; 2015 Jun; 16(3):418-24. PubMed ID: 25047808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutisches Management kutaner und genitaler Warzen.
    Ockenfels HM
    J Dtsch Dermatol Ges; 2016 Sep; 14(9):892-900. PubMed ID: 27607029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A controlled study of internalizing symptoms in older adolescents with sickle cell disease.
    Kelly AD; Egan AM; Reiter-Purtill J; Gerhardt CA; Vannatta K; Noll RB
    Pediatr Blood Cancer; 2015 Apr; 62(4):637-42. PubMed ID: 25556914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Developing a Problem-solving Intervention to Improve Self-Management and Transition Readiness in Adolescents with Sickle Cell Disease.
    Melita N; Diaz-Linhart Y; Kavanagh PL; Sobota A
    J Pediatr Nurs; 2019; 46():26-32. PubMed ID: 30826724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nursing management of children with sickle cell disease: an update.
    Gribbons D; Zahr LK; Opas SR
    J Pediatr Nurs; 1995 Aug; 10(4):232-42. PubMed ID: 7562380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Picturing the Experience of Living With Myotonic Dystrophy (DM1): A Qualitative Exploration Using Photovoice.
    LaDonna KA; Venance SL
    J Neurosci Nurs; 2015 Oct; 47(5):285-95. PubMed ID: 26348433
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adolescents with sickle cell disease: determinants of support group attendance and satisfaction.
    Telfair J; Gardner MM
    Health Soc Work; 2000 Feb; 25(1):43-50. PubMed ID: 10689602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.